T50 — Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
Is T50 billable?
No — T50 is a non-billable header code. T50 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 60 billable codes beneath T50.
Billable codes under this header
- T50.0X1APoisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
- T50.0X1DPoisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
- T50.0X1SPoisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
- T50.0X2APoisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
- T50.0X2DPoisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
- T50.0X2SPoisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
- T50.0X3APoisoning by mineralocorticoids and their antagonists, assault, initial encounter
- T50.0X3DPoisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
- T50.0X3SPoisoning by mineralocorticoids and their antagonists, assault, sequela
- T50.0X4APoisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
- T50.0X4DPoisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
- T50.0X4SPoisoning by mineralocorticoids and their antagonists, undetermined, sequela
- T50.0X5AAdverse effect of mineralocorticoids and their antagonists, initial encounter
- T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequela
- T50.0X6AUnderdosing of mineralocorticoids and their antagonists, initial encounter
- T50.0X6DUnderdosing of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X6SUnderdosing of mineralocorticoids and their antagonists, sequela
- T50.1X1APoisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter
- T50.1X1DPoisoning by loop [high-ceiling] diuretics, accidental (unintentional), subsequent encounter
- T50.1X1SPoisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela
- T50.1X2APoisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter
- T50.1X2DPoisoning by loop [high-ceiling] diuretics, intentional self-harm, subsequent encounter
- T50.1X2SPoisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela
- T50.1X3APoisoning by loop [high-ceiling] diuretics, assault, initial encounter
- T50.1X3DPoisoning by loop [high-ceiling] diuretics, assault, subsequent encounter
- T50.1X3SPoisoning by loop [high-ceiling] diuretics, assault, sequela
- T50.1X4APoisoning by loop [high-ceiling] diuretics, undetermined, initial encounter
- T50.1X4DPoisoning by loop [high-ceiling] diuretics, undetermined, subsequent encounter
- T50.1X4SPoisoning by loop [high-ceiling] diuretics, undetermined, sequela
- T50.1X5AAdverse effect of loop [high-ceiling] diuretics, initial encounter
- T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X5SAdverse effect of loop [high-ceiling] diuretics, sequela
- T50.1X6AUnderdosing of loop [high-ceiling] diuretics, initial encounter
- T50.1X6DUnderdosing of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X6SUnderdosing of loop [high-ceiling] diuretics, sequela
- T50.2X1APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter
- T50.2X1DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), subsequent encounter
- T50.2X1SPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela
- T50.2X2APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter
- T50.2X2DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, subsequent encounter
- T50.2X2SPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela
- T50.2X3APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter
- T50.2X3DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, subsequent encounter
- T50.2X3SPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela
- T50.2X4APoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter
- T50.2X4DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, subsequent encounter
- T50.2X4SPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela
- T50.2X5AAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.2X6AUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X6DUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X6SUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.3X1APoisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter
- T50.3X1DPoisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), subsequent encounter
- T50.3X1SPoisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela
- T50.3X2APoisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter
- T50.3X2DPoisoning by electrolytic, caloric and water-balance agents, intentional self-harm, subsequent encounter
- T50.3X2SPoisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela
T50 at a glance
| Code | T50 |
|---|---|
| Description | Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T50 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T50. T50 describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T50 to fully describe the condition. T50 is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T50 to fully describe the condition. T50 is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T50, but a patient may have both at the same time. When documentation supports it, T50 and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T50, but a patient may have both at the same time. When documentation supports it, T50 and the excluded code may both be reported.
What codes fall under T50? (13)
- T50.0Poisoning by, adverse effect of and underdosing of mineralocorticoids and their antagonistsnot billable
- T50.1Poisoning by, adverse effect of and underdosing of loop [high-ceiling] diureticsnot billable
- T50.2Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diureticsnot billable
- T50.3Poisoning by, adverse effect of and underdosing of electrolytic, caloric and water-balance agentsnot billable
- T50.4Poisoning by, adverse effect of and underdosing of drugs affecting uric acid metabolismnot billable
- T50.5Poisoning by, adverse effect of and underdosing of appetite depressantsnot billable
- T50.6Poisoning by, adverse effect of and underdosing of antidotes and chelating agentsnot billable
- T50.7Poisoning by, adverse effect of and underdosing of analeptics and opioid receptor antagonistsnot billable
- T50.8Poisoning by, adverse effect of and underdosing of diagnostic agentsnot billable
- T50.APoisoning by, adverse effect of and underdosing of bacterial vaccinesnot billable
- T50.BPoisoning by, adverse effect of and underdosing of viral vaccinesnot billable
- T50.ZPoisoning by, adverse effect of and underdosing of other vaccines and biological substancesnot billable
- T50.9Poisoning by, adverse effect of and underdosing of other and unspecified drugs, medicaments and biological substancesnot billable
How long has T50 existed?
T50 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.